UnitedHealth Group Inc shares rise premarket after mixed third quarter results

Andrew Cummings
October 17, 2017

816.36 million shares or 0.29% more from 813.97 million shares in 2017Q1 were reported. UnitedHealth Group's dividend payout ratio is presently 35.13%. Following the transaction, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. Additionally UnitedHealth Group Incorporated declared a dividend for shareholders that was paid on Tuesday September 19th, 2017. It has outperformed by 16.06% the S&P500.

Among 24 analysts covering UnitedHealth Group (NYSE:UNH), 24 have Buy rating, 0 Sell and 0 Hold. Therefore 38% are positive. Mizuho maintained it with "Buy" rating and $235.0 target in Friday, October 6 report.

A number of research analysts recently commented on the company. The rating was downgraded by RBC Capital Markets to "Sector Perform" on Monday, July 24. On Wednesday, September 16 the stock rating was initiated by JP Morgan with "Overweight". The rating was maintained by Cowen & Co with "Buy" on Friday, August 11. (VZ) Ex-Dividend Date Scheduled for October 06, 2017" published on October 05, 2017 as well as Nasdaq.com's news article titled: "Telecom Stock Roundup: "Verizon Unveils New Prepaid Plan, Qualcomm Offers ..." with publication date: "October 12, 2017. Stockholders of record on Friday, September 8th were issued a $0.75 dividend. Pivotal Research has "Buy" rating and $45 target. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. The rating was downgraded by Macquarie Research on Wednesday, September 27 to "Neutral". The stock has "Overweight" rating by Morgan Stanley on Wednesday, June 7. The stock rose 0.36% or $0.7 reaching $193.9. $8.23M worth of stock was sold by BURKE RICHARD T on Thursday, May 4.


UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The company has market cap of $192.65 million.

After largely pulling out of individual insurance exchanges this year, UnitedHealth's new Chief Executive Officer Dave Wichmann said the company only had about 30,000 customers receiving subsidies in four states and that any impact would be "extremely small". Also, it has an estimated price-earnings (P/E) multiple of 17.81 and a trailing 12-month price-earnings (P/E) multiple of 23.23. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Investors sentiment increased to 1.02 in Q2 2017. Its down 0.34, from 1.22 in 2017Q1. These holdings make up 87.77% of the company's outstanding shares. 122 funds opened positions while 438 raised stakes. Adage Capital Partners Gp L.L.C., a Massachusetts-based fund reported 1.95 million shares. Cap Invest Counsel stated it has 0.9% in UnitedHealth Group Inc (NYSE:UNH). The rating was downgraded by Needham to "Hold" on Thursday, December 17.


The collective rating of 1.5 for UnitedHealth Group Incorporated (NYSE:UNH) also leans strongly towards the bullish end of the spectrum. Glenmede Communications Na holds 2,977 shares. The stock traded on unusually Dropped volume of 4.59 Million comparing to the average volume of 6633.86 shares, completing picture of exact trends with uncompleted dots in volume over the norm. 12,886 are owned by Centurylink Investment Mngmt. South Texas Money Management Ltd invested 0.06% of its portfolio in UnitedHealth Group Inc (NYSE:UNH).

Now insiders hold 7,835,470 shares in the business which makes up 0.81% of shares. Koshinski Asset Mgmt, Illinois-based fund reported 6,799 shares. Sell-side analyst recommendations point to a short term price target of $39.86 on the company shares. Finally, Hanson McClain Inc. increased its stake in UnitedHealth Group by 1.7% in the first quarter.

The stock of UnitedHealth Group Inc (NYSE:UNH) hit a new 52-week high and has $217.62 target or 7.00% above today's $203.38 share price. The firm has "Buy" rating by Jefferies given on Friday, October 13. BMO Capital Markets maintained ResMed Inc. On Tuesday, July 18 the stock rating was maintained by Mizuho with "Buy". Cantor Fitzgerald maintained the stock with "Buy" rating in Wednesday, August 16 report. Lake Street has "Buy" rating and $15 target. About 2.68M shares traded. Clearfield Inc (NASDAQ:CLFD) has declined 19.57% since October 17, 2016 and is downtrending. It has underperformed by 53.21% the S&P500.


Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by iNewsToday

FOLLOW OUR NEWSPAPER